Depression in neurological practice: diagnosis, treatment, implications

Area of Science:

• Neurology
• Psychiatry
• Clinical Medicine

Background:

• Significant depressive syndromes are highly prevalent in general neurology clinics, affecting 15-20% of patients.
• These conditions contribute substantially to patient morbidity and mortality.
• Limited psychiatric resources necessitate broader involvement in depression treatment.

Purpose of the Study:

• To provide neurologists with a practical framework for diagnosing depressive disorders encountered in their practice.
• To outline steps for managing antidepressant therapies within a neurology setting.
• To introduce the Goldman algorithm as a tool for therapeutic decision-making in depression treatment.

Main Methods:

• Review of diagnostic and treatment strategies for depression in neurology.
• Presentation of the Goldman algorithm for antidepressant selection.
• Guidance on integrating depression management into routine neurological care.

Main Results:

• High ambulatory prevalence rates of depression in neurology clinics underscore the need for clinician training.
• Neurologists are increasingly involved in antidepressant therapy due to psychiatrist shortages.
• The Goldman algorithm offers a structured approach to treatment selection.

Conclusions:

• Neurologists play a critical role in identifying and managing depression in their patients.
• Accessible diagnostic and treatment guidelines are essential for improving patient outcomes.
• The Goldman algorithm can empower neurologists to effectively manage depression.